Establishment and characterization of a Kaposi's sarcoma-associated herpesvirus- and Epstein-Barr virus-negative malignant lymphoma cell line (OHK) with primary effusion lymphoma immunophenotype

British Journal of Haematology

Volumn 116, Issue 1, 2002, Pages 128-134

  Mori, Hiroshi ^a   Kuwabara, Hiroko ^a   Suzuki, Koichi ^b   Tasaka, Taizo ^b   Ohmori, Minoru ^b   Kawakami, Kimihiro ^b   Nagai, Masami ^b   Yamaoka, Genji ^c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Internal Medicine and Diagnostic Pathology   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

Cell lines; EBV; KSHV HHV 8; PEL; VEGF

Indexed keywords

CD30 ANTIGEN; CD33 ANTIGEN; COLONY STIMULATING FACTOR 1; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 6; SYNDECAN 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ARTICLE; ASCITES; B CELL LYMPHOMA; B LYMPHOCYTE DIFFERENTIATION; CASE REPORT; CELL NUCLEUS; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; GOLGI COMPLEX; HERPES VIRUS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTERMEDIATE FILAMENT; KAPOSI SARCOMA; LYMPHOMA CELL LINE; NUCLEOLUS; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; ROUGH ENDOPLASMIC RETICULUM; SOUTHERN BLOTTING; STRUCTURE ANALYSIS; VIRUS DETECTION;

ASCITIC FLUID; CHROMOSOME ABERRATIONS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-6; LYMPHOKINES; LYMPHOMA, B-CELL; MACROPHAGE COLONY-STIMULATING FACTOR; MIDDLE AGED; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036162096     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03244.x     Document Type: Article

References (34)

1. Primary body cavity-based AIDS-related lymphomas
2. Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas
3. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus
4. Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells
5. Characterization of a new IL-6-dependent B-lymphoma cell line in long term culture
6. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice
7. The tyrosine kinase receptor Met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma
8. Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions
9. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1
10. Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8
11. Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma
12. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
13. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
14. Kaposi's sarcoma-associated herpesvirus in non-AIDS-related lymphomas occurring in body cavities
15. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
16. Single-step method of RNA isolation by acid guanidinium thiocyanate-PhOH-chloroform extraction
17. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma
18. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines
19. Immunologic markers in non-Hodgkin's lymphoma
20. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen
21. An International System for Human Cytogenetic Nomenclature. Report of the standing committee on human cytogenetic nomenclature
22. Hematopathology: Integration of morphologic features and biologic markers for diagnosis
23. Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma
24. CD138-positive and Kaposi's sarcoma-associated herpesvirus (KSHV)-negative B-cell lymphoma with serosal spreading of the body cavity and lymphadenopathy: An autopsy case
25. Expression of syndecan-1 inhibits cell invasion into type I collagen
26. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation
27. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus
28. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
29. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen
30. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: Ultrastructural demonstration of herpesvirus in lymphoma cells
31. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix
32. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
33. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry
34. Epstein-Barr virus-associated leiomyosarcomas in liver transplantation recipients: Origin from either donor or recipient tissue